Skip to main content

Abbott Laboratories

Financial Performance

Abbott Laboratories Revenue & Financials

Revenue

$40.3B (FY2024)

Net Income

$5.6B

Employees

114,000

What is Abbott Laboratories's revenue?

Abbott Laboratories had $40.3B in revenue for fiscal year 2024, up 0.6% from 2023. Net income was $5.6B.

Latest revenue
$40.3B (FY2024)
Year-over-year
+0.6%
Growth rate (CAGR)
7.9% over 9 years
Peak revenue
$43.7B (FY2022)
Years of data
10
Employees
114,000
How much profit does Abbott Laboratories make?
Abbott Laboratories reported net income of $5.6B for fiscal year 2024.
How many employees does Abbott Laboratories have?
Abbott Laboratories has about 114,000 employees.

Financial Analysis

Abbott maintains an exemplary financial profile, generating over $40.3 billion in revenue and $5.6 billion in net income with strong operating cash flows that comfortably fund continuous R&D investment and consistent dividend growth.

Revenue Trend Analysis

YoY Change

+0.6%

9-Year CAGR

+7.9%

Peak Year

2022

Trend

Consistent Growth

Abbott Laboratories has 10 full fiscal year figures on this page, compounding at +7.9% annually over 9 years. The most recent year saw a 0.6% increase versus the prior year. Annual revenue peaked in fiscal year 2022 at $43.7B. Of 9 comparable year-over-year steps, 8 showed growth and 1 showed a decline.

Annual revenue history

Fiscal YearRevenueNet IncomeYoY Change
FY2024$40.3B$5.6B+0.6%
FY2023$40.1B$4.9B-8.1%
FY2022$43.7B$6.9B+1.3%
FY2021$43.1B$7.1B+24.5%
FY2020$34.6B$4.5B+8.5%
FY2019$31.9B$3.7B+4.3%
FY2018$30.6B$2.4B+11.6%
FY2017$27.4B$475M+31.3%
FY2016$20.9B$1.4B+2.2%
FY2015$20.4B$4.4B—

Click any row to see year details.

Keep researching Abbott Laboratories

Abbott Laboratories Revenue and Financial FAQ

What was Abbott's latest reported annual revenue?

In its latest audited financial reporting period, Abbott Laboratories recorded consolidated net revenue of $40,331,000,000, demonstrating durable revenue growth across its primary operating divisions.

How profitable is Abbott Laboratories?

Abbott generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings of $5.6 billion and superior return on equity throughout changing economic cycles.

What is Abbott's capital and liquidity position?

Abbott maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and asset totals exceeding $81.2 billion that provide substantial safety margins above statutory requirements.

Does Abbott distribute capital to shareholders?

Abbott executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page
CorpDigest. "Abbott Laboratories Revenue & Financials." CorpDigest, https://corpdigest.com/company/abbott-laboratories/financials.
Embed this data
<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Abbott Laboratories reported $40.3B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/abbott-laboratories/financials" target="_blank" rel="noopener">CorpDigest — Abbott Laboratories financials</a></div>

Related Financial Audits

Compare revenue, net income, and market cap scale

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.